Evaluation of Intestinal Secretion of Antibodies and Auto-antibodies Associated With Crohn's Disease

NCT00769236 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2026-05-07

No results posted yet for this study

Summary

We propose to study the intestinal secretion of ASCA by evaluating them in biopsy culture supernatants from a cohort of patients suffering from CD (n=80) and a cohort of control patients (UC (n=40) and patients without IBD (n=40 )).

Conditions

Interventions

OTHER

Blood sampling and biopsy

Biopsy and blood : Research for various antibodies

OTHER

Biopsy and blood sampling

Biopsy and blood : research for various antibodies

OTHER

Biopsy and blood sampling

Blood and biopsy : research for various antibodies

Sponsors & Collaborators

  • Assistance Publique Hopitaux De Marseille

    lead OTHER

Principal Investigators

  • Sophie Desplat-Jego, MD · Assistance Publique des Hopitaux de Marseille

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2010-05-31
Completion
2010-08-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00769236 on ClinicalTrials.gov